Drs. Frans W.G. Trouwen is the CEO and Founder of Liberi Group. His company is specialized in working with biotech companies on Business Development and Strategy for over 18 years. With team members in The Netherlands and Denmark, they work on Investment projects, M&A, co-development, and licensing. Over the last few years, the team has secured many deals for its clients. The network of Investment and Strategic Pharma companies of Liberi Group is spread all over Europe, the US, and Asia as well as South America and Russia/The Middle East. Frans Trouwen served as the CEO of Valletta Health B.V., a Dermatology spin out of the Academic University Amsterdam for over 10 years. Frans serves on several Boards.